CH646692A5 - Derivato del piridilmetano ad attivita lassativa, processo per la sua preparazione e composizioni farmaceutiche che lo contengono. - Google Patents
Derivato del piridilmetano ad attivita lassativa, processo per la sua preparazione e composizioni farmaceutiche che lo contengono. Download PDFInfo
- Publication number
- CH646692A5 CH646692A5 CH456780A CH456780A CH646692A5 CH 646692 A5 CH646692 A5 CH 646692A5 CH 456780 A CH456780 A CH 456780A CH 456780 A CH456780 A CH 456780A CH 646692 A5 CH646692 A5 CH 646692A5
- Authority
- CH
- Switzerland
- Prior art keywords
- pyridylmethane
- bis
- ethoxy
- preparation
- contain
- Prior art date
Links
- 230000002475 laxative effect Effects 0.000 title claims description 10
- 238000000034 method Methods 0.000 title claims description 9
- 230000008569 process Effects 0.000 title claims description 4
- 238000002360 preparation method Methods 0.000 title claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 title claims 2
- LJROKJGQSPMTKB-UHFFFAOYSA-N 4-[(4-hydroxyphenyl)-pyridin-2-ylmethyl]phenol Chemical compound C1=CC(O)=CC=C1C(C=1N=CC=CC=1)C1=CC=C(O)C=C1 LJROKJGQSPMTKB-UHFFFAOYSA-N 0.000 claims description 8
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 claims description 6
- NHSIAYALMFHUEY-UHFFFAOYSA-N 2-[bis[4-(1-ethoxyethoxy)phenyl]methyl]pyridine Chemical compound C(C)OC(C)OC1=CC=C(C=C1)C(C1=NC=CC=C1)C1=CC=C(C=C1)OC(C)OCC NHSIAYALMFHUEY-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- 239000003377 acid catalyst Substances 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 241001465754 Metazoa Species 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000000741 diarrhetic effect Effects 0.000 description 6
- 210000003608 fece Anatomy 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000010489 acacia gum Nutrition 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical group [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 229940125722 laxative agent Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- GOZDTZWAMGHLDY-UHFFFAOYSA-L sodium picosulfate Chemical compound [Na+].[Na+].C1=CC(OS(=O)(=O)[O-])=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OS([O-])(=O)=O)C=C1 GOZDTZWAMGHLDY-UHFFFAOYSA-L 0.000 description 2
- 229960005077 sodium picosulfate Drugs 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- RWGSRGOPTWWYPN-UHFFFAOYSA-N 2-benzyl-1H-pyridin-4-one Chemical compound O=C1C=CNC(CC=2C=CC=CC=2)=C1 RWGSRGOPTWWYPN-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 235000012712 vegetable carbon Nutrition 0.000 description 1
- 239000004108 vegetable carbon Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT23571/79A IT1121574B (it) | 1979-06-14 | 1979-06-14 | Nouvo composto ad attivita'lassativa,processo per la sua preparazione e composizioni farmaceutiche che lo contengono |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH646692A5 true CH646692A5 (it) | 1984-12-14 |
Family
ID=11208226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH456780A CH646692A5 (it) | 1979-06-14 | 1980-06-13 | Derivato del piridilmetano ad attivita lassativa, processo per la sua preparazione e composizioni farmaceutiche che lo contengono. |
Country Status (11)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1167197B (it) * | 1983-07-25 | 1987-05-13 | Bellon Roger Schoum Rbs Pharma | Impiego della fenpiramina quale farmaco antiaggregante piastrinico,vasodilatatore,antitrombotico e antianginoso |
| JPH01283222A (ja) * | 1988-05-10 | 1989-11-14 | Tokai Kapuseru Kk | ピコスルフアートナトリウム軟カプセル剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR75159E (enrdf_load_stackoverflow) * | 1961-09-08 | |||
| GB730243A (enrdf_load_stackoverflow) * | ||||
| US2764590A (en) * | 1952-03-17 | 1956-09-25 | Thomae Gmbh Dr K | Certain 4, 4'-disubstituted-diphenylpyridyl methanes and process |
-
1979
- 1979-06-14 IT IT23571/79A patent/IT1121574B/it active
-
1980
- 1980-06-10 DE DE19803021785 patent/DE3021785A1/de active Granted
- 1980-06-10 GB GB8018930A patent/GB2051801B/en not_active Expired
- 1980-06-12 MX MX808872U patent/MX5881E/es unknown
- 1980-06-13 FR FR8013234A patent/FR2459232A1/fr active Granted
- 1980-06-13 BE BE2/58605A patent/BE883804A/nl not_active IP Right Cessation
- 1980-06-13 AR AR281393A patent/AR223223A1/es active
- 1980-06-13 NL NL8003465A patent/NL8003465A/nl not_active Application Discontinuation
- 1980-06-13 JP JP8082880A patent/JPS568366A/ja active Granted
- 1980-06-13 CH CH456780A patent/CH646692A5/it not_active IP Right Cessation
- 1980-06-13 ES ES492397A patent/ES8104799A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES492397A0 (es) | 1981-05-16 |
| IT7923571A0 (it) | 1979-06-14 |
| GB2051801B (en) | 1983-03-09 |
| NL8003465A (nl) | 1980-12-16 |
| JPS5745431B2 (enrdf_load_stackoverflow) | 1982-09-28 |
| MX5881E (es) | 1984-08-16 |
| IT1121574B (it) | 1986-04-02 |
| DE3021785A1 (de) | 1980-12-18 |
| AR223223A1 (es) | 1981-07-31 |
| FR2459232B1 (enrdf_load_stackoverflow) | 1984-05-18 |
| ES8104799A1 (es) | 1981-05-16 |
| JPS568366A (en) | 1981-01-28 |
| GB2051801A (en) | 1981-01-21 |
| BE883804A (nl) | 1980-10-01 |
| FR2459232A1 (fr) | 1981-01-09 |
| DE3021785C2 (enrdf_load_stackoverflow) | 1988-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR880001714B1 (ko) | 벤즈이미다졸 유도체의 제조 방법 | |
| EP2186792B1 (en) | 2-(a-hydroxypentyl) benzoate and its preparation and use | |
| US3818035A (en) | 2{8 (2-ALKYLBENZO{8 b{9 {11 FURAN-3 yl)METHYL{9 -{66 {11 IMIDAZOLINE | |
| US20130281535A1 (en) | Lipid-lowering antidiabetic agent | |
| JPH0136819B2 (enrdf_load_stackoverflow) | ||
| JPH0211579B2 (enrdf_load_stackoverflow) | ||
| US5190947A (en) | Codeine salt of a substituted carboxylic acid, its use and pharmaceutical compositions thereof | |
| CH646692A5 (it) | Derivato del piridilmetano ad attivita lassativa, processo per la sua preparazione e composizioni farmaceutiche che lo contengono. | |
| US3519717A (en) | Novel method for lowering high blood pressure and compositions therefor | |
| AU2017213007B2 (en) | Application of substituted cinnamamide derivatives in preparation of anti-anxiety medications | |
| US4501752A (en) | Antiulcer drug | |
| JPS58192825A (ja) | グリセロール誘導体 | |
| GB1587128A (en) | Benzothiazepine derivatives | |
| PT97487A (pt) | Processo para a preparacao de sais de derivados de furano e de um complexo de bismuto com um acido carboxilico terapeuticamente uteis | |
| JP3110500B2 (ja) | 血糖上昇抑制剤 | |
| DE2038835A1 (de) | 1,10-Bis(carboxyalkylenthio)-decane | |
| JPH0327312A (ja) | 血小板凝集抑制剤 | |
| Ainsworth et al. | Cholesterol-solubilizing agents related to the gallstone problem | |
| US3980782A (en) | Inhibition of gastric acid secretion with phenyl-substituted perimidines | |
| JPH09500863A (ja) | タモキシフェン抵抗性腫瘍の処置用の非代謝性クロミフェン類似体類 | |
| RU2067979C1 (ru) | Производное аминобензойной кислоты или его фармацевтически приемлемая соль | |
| PL99800B1 (pl) | Sposob wytwarzania nowych pochodnych benzhydrylooksyalkiloaminy | |
| SU1001855A3 (ru) | Способ получени 2-замещенных-1н-фенантро[9,10- @ ]имидазолов или их солей | |
| US3708581A (en) | Anti-inflammatories | |
| US4507288A (en) | β-Glycerophosphate salts of antimalarial phenanthrenemethanol compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |